Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vector.

Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vector.
复制标题

将编码人类酸性 α-葡萄糖苷酶的 AAV 载体与改良的杂合腺病毒-AAV 载体包装在一起,用于 II 型糖原贮积病的基因治疗。

DOI:
10.1016/s1525-0016(03)00022-4
复制
发表时间:
2003
期刊:
Molecular therapy : the journal of the American Society of Gene Therapy
影响因子:
--
通讯作者:
Koeberl,DwightD
Koeberl,DwightD
中科院分区:
--
文献类型:
--
作者:
Sun,Baodong;Chen,Y-T;Bird,Andrew;Xu,Fang;Hou,Yang-Xun;Amalfitano,Andrea;Koeberl,DwightD

文献摘要

参考文献

被引文献

相似文献

We have developed an improved method for packaging adeno-associated virus (AAV) vectors with a replication-defective adenovirus-AAV (Ad-AAV) hybrid virus. The AAV vector encoding human acid α-glucosidase (hGAA) was cloned into an E1, polymerase/preterminal protein-deleted adenovirus, such that it is packaged as an Ad vector. Importantly, the Ad-AAV hybrid cannot replicate during AAV vector packaging in 293 cells, because of deletion of polymerase/preterminal protein. The residual Ad-AAV in the AAV vector stock was reduced to <1 infectious particle per 1010AAV vector particles. These modifications resulted in ∼30-fold increased packaging of the AAV vector for the hybrid Ad-AAV vector method as compared with standard transfection-only methods. Similarly improved packaging was demonstrated for pseudotyping the AAV vector as AAV6, and for AAV vector packaging with a second Ad-AAV vector encoding canine glucose-6-phosphatase. Liver-targeted delivery of either the Ad-AAV hybrid or AAV vector particles in acid α-glucosidase-knockout (GAA-KO) mice revealed secretion of hGAA with the Ad-AAV vector, and sustained secretion of hGAA with an AAV vector in hGAA-tolerant GAA-KO mice. Further development of hybrid Ad-AAV vectors could offer distinct advantages for gene therapy in glycogen storage diseases.
DOI: 10.1161/01.hyp.13.6.954
发表时间: 1989-06-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
MACCARTHY, EP;YAMASHITA, W;OOI, BS
通讯作者: OOI, BS
1·25二羟基维生素d3对大鼠血管平滑肌细胞vsmc生长的调节作用
DOI: --
发表时间: 1988
期刊:
影响因子: --
作者:
E. Maccarthy;W. Yamashita;A. Hsu;B. S. Ooi
通讯作者: B. S. Ooi
DOI: 10.1161/01.res.61.2.181
发表时间: 1987-08-01
影响因子: 20.1
作者:
AALKJAER, C;HEAGERTY, AM;MULVANY, MJ
通讯作者: MULVANY, MJ
实验性高血压中的钙代谢
DOI: --
发表时间: 1988
期刊: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
影响因子: --
作者:
E. Young;R. Bukoski;D. McCarron
通讯作者: D. McCarron
自发性高血压大鼠血小板的钙处理异常。
DOI: 10.1161/01.hyp.15.6.606
发表时间: 1990
期刊: Hypertension
影响因子: 8.3
作者:
T. Oshima;E. Young;R. Bukoski;D. McCarron
通讯作者: D. McCarron